← Leaderboards
Jeffrey N Joyce
University Of Pennsylvania
$1,346,499
Attributed
$1,346,499
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,346,499 · 2
By mechanism
R01$1,129,533 · 1
P01$216,966 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- John Q. Trojanowski$38,320,321
- Virginia M Lee$38,958,370
- Victor W. Henderson$15,677,928
- Alice S Chen-Plotkin$18,977,934
- Murray Grossman$38,029,353
Others in their field
Top investigators on “Parkinson'S Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson'S DiseaseMolecular PathologyHuman TissueDopamine ReceptorBrain Disorder DiagnosisBrain MappingCell DeathClinical ResearchDementiaDopamineDrug ResistanceExtrapyramidal DisorderGenetically Modified AnimalsHistochemistry /CytochemistryHistopathologyImmunocytochemistryLaboratory MouseLewy BodyMesencephalonMessenger RnaNeural DegenerationNeurofilamentPathologic ProcessPostmortem
Grant awards (8)
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE$353,118
R01 · FY2002 · NS
DEGENERATION OF DOPAMINERGIC PATHWAYS$0
P01 · FY2002 · AG
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE$354,482
R01 · FY2001 · NS
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE$50,000
R01 · FY2001 · NS
DEGENERATION OF DOPAMINERGIC PATHWAYS$0
P01 · FY2001 · AG
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE$371,933
R01 · FY2000 · NS
DEGENERATION OF DOPAMINERGIC PATHWAYS$216,966
P01 · FY2000 · AG
DEGENERATION OF DOPAMINERGIC PATHWAYS$0
P01 · FY2000 · AG